2F-DCK 100 mg graanulit
2F-DCK 100 mg graanulit Hinnavahemik: €34.95 kuni €1,189.95
Tagasi toodete juurde
RC+ 4-fluori 120 mg blisterpakend
RC+ 4-fluori 120 mg blisterpakend €20.57
DCK (Deschloroketamine) - Pilt 1
DCK (Deschloroketamine) - Pilt 2

DCK (deskloroketamiin)

DCK properties

Sünonüüm: 2′-oxo-PCM, deschloroketamine
CAS-number: 4631-27-0
Valem: 2-(methylamino)-2-phenyl-cyclohexanone
Molaarmass: 239.7 g/mol
Puhtus: >97%

Hinnavahemik: €22.95 kuni €2,599.95

Lisa võrdlusse
Lisa soovinimekirja
SÄÄSTA 15%

veel 2 toodet

SÄÄSTA 50%

6 tk 3 hinnaga

* Sellel lehel olev teave on kokkuvõte ega ole mõeldud hõlmama kogu selle ravimi kohta kättesaadavat teavet. See ei hõlma kõiki võimalikke kasutusviise, juhiseid, ettevaatusabinõusid, ravimite koostoimeid ega kõrvaltoimeid ning ei asenda teie tervishoiutöötaja teadmisi ja hinnanguid.

Product Definition: DCK (Deschloroketamine) Research Chemicals

Keemiline nimetus:  Deschloroketamine hydrochloride
Sünonüümid:  DCK, 2′-Oxo-PCM
Molekulaarne valem:  C13H16NO•HCl
Molekulaarmass:  229.73 g/mol
CAS No.:  7061-51-4
Välimus:  White crystalline powder
Puhtus:  ≥98% (HPLC-ga kontrollitud)
Lahustuvus:  50 mg/ml in water

Description & Pharmacology:
DCK is a ketamine analog with potent NMDA receptor antagonism. This study substance exhibits:
✔Longer duration of action than ketamine (4-6 hours)
✔Potent dissociative properties
✔Potential antidepressant activity
✔Lower bladder toxicity than ketamine

Research applications:

  1. Neuroscientific research into:

    • NMDA receptor function

    • Rapid antidepressant mechanisms

    • Neuroplasticity

  2. Anesthesiological studies:

    • Dissociative anesthetics

    • Pain perception modulation

  3. Psychopharmacology:

    • Consciousness-altering effects

    • Dissociative states

Benefits for Research:
✅ Higher potency than ketamine (2-3x)
✅Longer duration of action (ideal for studies)
✅Less hepatotoxic than some analogs
✅Good oral bioavailability

Risks & Limitations:
❌ Possible side effects:

  • Hypertension

  • Disorientation

  • Nausea
    ❌Limited long-term studies available
    ❌Potential for dissociative episodes

Dosage protocol (for research):

Target levelDosage (oral)Expected effect
Mikrodoos5-10mgSubtle effects
Standardne15-30mgClear dissociation
Kõrge30-50mgStrong dissociative state

Safety measures:

  • Do not combine with:
    • MAO inhibitors
    • Other NMDA antagonists
    • CNS depressants

  • At least 1 week between examinations

Frequently Asked Questions:

  1. Is DCK legal in the Netherlands?
    DCK may fall under the Opium Act as a ketamine analogue.

  2. How does DCK differ from ketamine?
    Longer duration of action, higher potency, less bladder irritation.

  3. Can DCK be addictive?
    Frequent use can lead to tolerance.

  4. Is DCK detected in drug tests?
    It can cross-react with ketamine tests.

Quality Control & Analytical Data:

Spetsifikatsioonid:

  • Purity: ≥98% (HPLC)

  • Heavy metals: <2 ppm

  • Mikrobioloogia: <100 CFU/g

  • Residual solvents: <0.1%

Stability data:

  • Shelf life: 24 months at 15-25°C

  • Valgustundlikkus: Mõõdukas

  • Moisture sensitivity: High

Conclusion:
DCK offers valuable research opportunities for neuroscience and pharmacological studies, but requires strict ethical protocols.

⚠ For in vitro research only – not for human consumption

Säilitamisnõuanded:

  • Airtight packaging

  • Store in a dark place

  • Dry at <25°C

Ethical considerations: